Close Menu

Columbia

Snippets: Apr 8, 2009

Premium

Susan G. Komen for the Cure, Prostate Cancer Foundation, National Cancer Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases, and more …

Regeneron Inks mAb Pact with UT-Southwestern; Mount Sinai taps DiscoveryBioMed for bioassay services; Repligen licenses bipolar disorder Rx from Harvard's McLean, and more …

The saliva collection kit company will take samples for a Columbia University study at the National Walk for Epilepsy in Washington, DC.

The first version of the sequencer, about to enter beta-testing, will cost around $250,000 and will be able to generate several gigabases of data in a 5.5-hour run with $250 in consumables costs per gigabase. That price is expected to fall to as little as $2 with later generations.

Strands: Mar 12, 2009

Premium

Rosetta Genomics, Alnylam Pharmaceuticals, Massachusetts Institute of Technology

The firm published data from a study showing that the same biomarker used in its miRNA-based test for squamous lung cancer provided 96 percent sensitivity.

As part of the arrangement, Columbia and the University of Nebraska-Lincoln signed an inter-institutional agreement that makes Columbia the lead on patent prosecution and negotiations, but gives both universities and their faculty inventors an undisclosed equity stake in the company.

Battelle Ventures, MIT, Hepragen, Wayne State University, Defyrus, UK Ministry of Defence, Columbia U, Intelligent Bio-Systems, Kauffman Foundation

The company will use the funds to develop protein-based Alzheimer's diagnostics.

Microarrays

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.